ELCC 2026: Co-mutations in EGFR-mutated NSCLC
In this MEDtalk from ELCC 2026, Fredrik Enlund, Associate Professor and Head of Diagnostic Center at Kalmar County Hospital, presents a pilot study of patients with EGFR-mutated lung adenocarcinoma. NGS analysis identified additional mutations, including RET and HIF-1, that differed between patients with shorter and longer survival.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
